In Vitro Activity of the New Oxazolidinone AZD2563 against Enterococci
- 1 October 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (10) , 3273-5
- https://doi.org/10.1128/aac.46.10.3273-3275.2002
Abstract
The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci representing six species. All isolates, including those resistant to other antibiotic classes, were inhibited by AZD2563 at concentrations ≤2 μg/ml, except for four strains resistant to linezolid. In most cases, AZD2563 was twofold more active than linezolid against enterococci.Keywords
This publication has 3 references indexed in Scilit:
- OxazolidinonesDrugs, 2000
- Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from the United States and Their Susceptibility In Vitro to Dalfopristin-QuinupristinAntimicrobial Agents and Chemotherapy, 1998
- Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 1998